Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
EPS (Diluted)
Palla Pharma Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Palla Pharma Ltd
ASX:PAL
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-38%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
ASX:ADO
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
ASX:CTE
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Genetic Signatures Ltd
ASX:GSS
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's EPS (Diluted)?
EPS (Diluted)
-0.4
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's EPS (Diluted) amounts to -0.4 AUD.
What is Palla Pharma Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
1%
Over the last year, the EPS (Diluted) growth was -282%. The average annual EPS (Diluted) growth rates for Palla Pharma Ltd have been -38% over the past three years , 1% over the past five years .